- Linkage Home
- GWAS: Toward a Comprehensive Understanding of Cancer Causation
- Visiting Scholar William Blot
- Spring 2009 Intramural Research Awards
- Profile of William Anderson
- Drs. Linet and Hartge Recognized by the InterLymph Consortium
- Profile of Ruth Kleinerman
- DCEG Selects the First Robert A. Welch Fellow
- Sallie Rosen Kaplan Fellows
- International Conference on Radiation
- New TEQ Chair
- DCEG Staff Attend the Society for Epidemiologic Research Meeting
- Fellows Win NIH FARE Awards
- DCEG Staff Win NIH Plain Language Awards
- Annual Summer Fellows Event
- Kenneth Cantor Retires
- Staff Receive NIH Merit Awards
- Alumna Dr. Peters Selected for the PECASE Award
- Charles Land Retires
- Scientific Highlights
- Major Editorials, Commentaries, and Reviews Published by DCEG Scientists in 2009
- DCEG People in the News
- NIH Juried Art Show
- Dr. Linet Inducted into the Johns Hopkins Society of Scholars
- Administrative Resource Center Updates
- Comings...Goings
- Highly Cited Papers by DCEG
- DCEG Participates in ACE Meeting
Drs. Linet and Hartge Recognized by the InterLymph Consortium
Patricia Hartge and Martha Linet.
The International Consortium of Investigators Working on Non-Hodgkin Lymphoma Epidemiology Studies, referred to as InterLymph or the InterLymph Consortium, honored Martha S. Linet, M.D., M.P.H., Chief of the Radiation Epidemiology Branch, and Patricia Hartge, Sc.D., Epidemiology and Biostatistics Program, at the InterLymph 2009 Annual Scientific Meeting in Vancouver. The consortium members presented Drs. Linet and Hartge with Awards for Outstanding Service in recognition of their insight, initiative, and key roles in founding InterLymph. Both have served in the governing group, on working panels devoted to specific projects, and as authors on reports of pooled analyses conducted by the consortium.
Founded in 2001, InterLymph has served as an open scientific forum for epidemiologic research on non-Hodgkin lymphoma. Supported by DCEG, the Division of Cancer Control and Population Sciences, the International Agency for Research on Cancer in Lyon, France and the Leukemia Research Fund in London, the international consortium consists of investigators who have completed or who have ongoing case-control studies of lymphoma and who undertake large-scale collaborative research projects that pool data across the individual studies.
